Healthleap Raises $38 Million to Expand Hospital AI Platform

How is Healthleap's $38 million funding structured?

The $8 million seed round was co-led by Sequoia Capital and First Round Capital, while Hummingbird Ventures led the $30 million Series A; Healthleap did not disclose its valuation.

Orbitrum Investor Impact

Why does the funding matter for Healthleap?

The capital gives Healthleap more resources for engineering, product, sales and customer success as it scales a business that CEO Josiah Meyer said grew revenue more than 10x and hospital partners from three to more than 50 over the past year.

How does Healthleap make money?

Healthleap sells three-year contracts priced according to a hospital's licensed bed count and also uses outcome-based pricing tied to measurable financial results.

Does Healthleap's AI diagnose patients?

No. The platform analyzes hospital records and surfaces risk scores for clinical review, while clinicians remain responsible for diagnosis and treatment decisions.

What evidence supports Healthleap's hospital economics?

Healthleap reports $23.8 million of annualized financial impact from its malnutrition program at one Penn Medicine hospital, including $6.3 million of additional reimbursement and $17.5 million attributed to shorter stays; these are company-reported deployment results rather than a forecast for every customer.

What happens next for Healthleap?

Healthleap plans to use the funding to broaden its platform beyond malnutrition and delirium, with additional conditions still undergoing clinical validation and a longer-term goal of covering more than 40 major conditions and expanding into outpatient and home care.